Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 5, 2003, Pages 2180-2184

  Morissette, Sherry L ^a   Soukasene, Stephen ^a   Levinson, Douglas ^a   Cima, Michael J ^b   Almarsson, Örn ^a  

^a TransForm Pharmaceuticals Inc   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; RITONAVIR;

ARTICLE; CAPSULE FILLING; CRYSTALLIZATION; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; ENZYME POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PARTICLE SIZE; PRIORITY JOURNAL; PROTEINASE INHIBITION; STRUCTURE ANALYSIS;

CRYSTALLOGRAPHY, X-RAY; HIV PROTEASE INHIBITORS; PEPTIDES; RITONAVIR; SPECTRUM ANALYSIS, RAMAN; TEMPERATURE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0037418267     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0437744100     Document Type: Article

References (17)

1. McCrone, W. C. (1965) in Physics and Chemistry of the Organic Solid State, eds. Fox, D., Labes, M. M. & Weissberger, A. (Wiley, New York), Vol. 2, pp. 725-767.
2. Grant, D. J. W. (1999) in Polymorphism in Pharmaceutical Solids, Drugs and the Pharmaceutical Sciences, ed. Brittain, H. (Dekker, New York), Vol. 95, pp. 1-33.
3. Peterson, M. L., Morissette, S. L., McNulty, C., Goldsweig, A., Shaw, P., LeQuesne, M., Monagle, J., Encina, N., Marchionna, J., Johnson, A., et al. (2002) J. Am. Chem. Soc. 124, 10958-10959.
4. Gardner, C., Almarsson, Ö., Chen, H., Morissette, S., Peterson, M., Zhang, Z., Wang, S., Lemmo, T., Gonzalez-Zugasti, J., Monagle, J., et al. (2003) Proceedings of the Fourth International Conference on Foundations of Computer-Aided Process Operations, eds. Grossmann, I. E. & McDonald, C. M., in press.
5. Chen, H., Read, M., Morissette, S. & Gardner, C. (2003) Targets, in press.
6. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. & Markowitz, M. (1995) Nature 373, 123-126.
7. Kempf, D: J. J., Marsh, K. C., Denissen, J. F., McDonald, E., Vasavanonda, S., Flentge, C. A., Green, B. E., Fino, L., Park, C. H., Kong, X., et al. (1995) Proc. Natl. Acad. Sci. USA 92, 2484-2488.
8. Bauer, J., Spanton, S., Henry, R., Quick, J., Dziki, W., Porter, W. & Morris, J. (2001) Pharm. Res. 18, 859-866.
9. Law, D., Krill, S. L., Schmitt, E. A., Fort, J. J., Qiu, Y., Wang, W. & Porter, W. R. (2001) J. Pharm. Sci. 90, 1015-1025.
10. Chemburkar, S. R., Bauer, J., Deming, K., Spiwek, H., Patel, K., Morris, J., Henry, R., Spanton, S., Dziki, W., Porter, W., et al. (2000) Org. Proc. Res. Dev. 4, 413-417.
11. Anonymous (July 27, 1998) PR Newswire.
12. Anonymous (August 3, 1998) Marketletter Ltd.
13. Dunitz, J. D. & Bernstein, J. (1995) Acc. Chem. Res. 28, 193-200.
14. Byrn, S. R., Pfeiffer, R. R. & Stowell, J. G. (1999) Solid-State Chemistry of Drugs (SSCI, West Lafayette, IN), pp. 23-25.
15. Chen, L. R., Young, V. G., Lechuga-Ballesteros, D. & Grant, D. J. W. (1999) J. Pharm. Sci. 88, 1191-1200.
16. Allen, K., Davey, R. J., Ferrari, E., Towler, C., Tiddy, G. J., Jones, M. O. & Pritchard, R. G. (2002) Cryst. Growth Des. 2, 523-527.
17. Lide, D. R., ed. (2002) CRC Handbook of Chemistry and Physics (CRC Press, Boca Raton, FL), 83rd Ed., Section 6, pp. 154-155.